News And Events

Pharma News March To April 2018 Highlights

• Doctor’s Protest: Days after Prime Minister Narendra Modi accused Indian doctors of having a nexus with pharmaceutical companies for unethical rewards. Across India, over 3 lakh member doctors of the the Indian Medical Association (IMA) responded to the PM’s remarks by wearing black ribbon around their arms. • Professionals from the pharma and healthcare …

Pharma News March To April 2018 Highlights Read More »

Major Pharma News Highlights, October to December 2017

Torrent Pharma to buy Unichem’s India business: Torrent Pharmaceuticals  has entered into a agreement with Unichem to buy its business in India, Nepal for Rs3,600 crore. Ajanta Pharma retains the tag of fastest wealth creator for the third time in a row: TCS biggest wealth creator in 2012-17, Ajanta Pharma the fastestweath creator in 2017. Asian …

Major Pharma News Highlights, October to December 2017 Read More »

Pharma News, August And September 2017, Highlights Pill

Govt proposal to scrap loan licensing in draft pharma policy faces flak: The draft pharma policy’s plan to do away with loan licensing would lead to revenue loss for SMEs, disrupt the supply chain and make installed capacities redundant, says industry. IDMA said that more than 40% of drug production is generated through loan licensing. The …

Pharma News, August And September 2017, Highlights Pill Read More »

July 2017. Major Pharma News Highlights Pill

Sun Pharma has appointed Samsung BioLogics to manufacture Tildrakizumab, an investigational IL-23p19 inhibitor being evaluated for the treatment of moderate to severe plaque psoriasis. The Centre has stalled a $1.3-billion bid by Shanghai Fosun Pharmaceutical Group (SFP) to acquire an 86% stake+ in Hyderabad-based Gland Pharma, citing “genuine concerns” over proprietary technology developed by the …

July 2017. Major Pharma News Highlights Pill Read More »

Pharma News, May 2017 Major Highlights Pill

Cadila Healthcare Ltd has become India’s second-most valuable pharmaceutical company in terms of market capitalisation, ahead of drug makers such as Lupin Ltd, Dr Reddy’s Laboratories Ltd and Cipla Ltd that have higher revenues. Now it ranks at the 47th position in overall market cap among all industries ranking on the BSE. Sun Pharmaceuticals Industries Ltd …

Pharma News, May 2017 Major Highlights Pill Read More »

NIPER Mohali Second Rank in Pharmacy Category, Vows to reach Top

NIPER mohali participated first time in a survey conducted by National Institutional Ranking Framework (NIRF), Ministry of Human Resource Development, Government of India for National Ranking of the Institutes / Universities. It has adjudged, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar (Mohali) Second in the country in Pharmacy category. As per data …

NIPER Mohali Second Rank in Pharmacy Category, Vows to reach Top Read More »

Language »